Oblinger, Janet L.
Wang, Jack
Wetherell, Georgia D.
Agarwal, Garima
Wilson, Tyler A.
Benson, Nicole R.
Fenger, Joelle M.
Fuchs, James R.
Kinghorn, A. Douglas
Chang, Long-Sheng
Funding for this research was provided by:
National Cancer Institute
Congressionally Directed Medical Research Programs
CancerFree KIDS
Rally Foundation/The Truth365/The Power of Will
Sunbeam Foundation
Article History
Received: 29 May 2024
Accepted: 1 August 2024
First Online: 20 August 2024
Competing interests
: LSC and ADK have submitted a US patent application on Anticancer Rocaglamide Derivatives (Serial No. 17/284,112). All other authors declare no competing interests.